Clinical Trials Browser

Phase 2 × Potassium Iodide × Lymphoid × Clear all

NCT00490009 2017-03-30

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

Phase 2 Completed

9 enrolled 10 charts

Lymphoma

NCT00490490 2017-03-29

Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy

Phase 2 Terminated

8 enrolled 11 charts

Lymphoma, Non-Hodgkin